Dysphoric mania induced by high-dose mirtazapine: A case for 'norepinephrine syndrome'?

International Clinical Psychopharmacology

Volumn 17, Issue 6, 2002, Pages 319-322

  Bhanji, Nadeem H ^a   Margolese, Howard C ^a   Saint Laurent, M ^a   Chouinard, Guy ^a  

^a Allan Memorial Institute   (Canada)

Author keywords

Adverse effects; Mania; Mirtazapine; Noradrenergic; Norepinephrine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; FLUOXETINE; GABAPENTIN; HISTAMINE H1 RECEPTOR; LITHIUM CARBONATE; MIRTAZAPINE; MOCLOBEMIDE; NORADRENALIN; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; CASE REPORT; DEPRESSION; DISEASE PREDISPOSITION; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; DYSPHORIA; FEMALE; GAIT DISORDER; HUMAN; INSOMNIA; IRRITABILITY; MANIA; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RESTLESSNESS;

EID: 0036840151     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200211000-00009     Document Type: Article

References (17)

1. American Psychiatric Association (2001) Diagnostic and Statistical Manual of Mental Disorders, 4th Edn. Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Press.
2. Bailer U, Fischer P, Kufferle B, Stastny J, Kasper S (2000) Occurrence of mirtazapine-induced delirium in organic brain disorder. Int Clin Psychopharmacol 15:239-243.
3. Benazzi F (1998) Serotonin syndrome with mirtazapine-fluoxetine combination. Int J Geriatr Psychiatry 13:495-496.
4. Charney DS, Heninger GR, Sternberg DE, Landis H (1982) Abrupt discontinuation of tricyclic antidepressant drugs: Evidence for noradrenergic hyperactivity. Br J Psychiatry 141:377-386.
5. DeLeon, Furmage KM, Kalsounis J (1999) Mirtazapine-induced mania in a case of poststroke depression. J Neuropsychiatry Clin Neurosci 11:115-116.
6. Demers JC, Malone M (2001) Serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 35:1217-1220.
7. Dording CM (2000) Antidepressant augmentation and combinations. Psychiatr Clin North Am 23:743-755.
8. Fawcett J, Barkin RL (1998) Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 51:267-285.
9. Hernandez JL, Ramos FJ, Infante J, Rebollo M, Gonzalez-Macias J (2002) Severe serotonin syndrome induced by mirtazapine monotherapy. Ann Pharmacother 36:641-643.
10. MacCall C, Callender J (1999) Mirtazapine withdrawal causing hypomania. Br J Psychiatry 175:390.
11. Montgomery SA (1995) Safety of mirtazapine: A review. Int Clin Psychopharmacology 10:37-45.
12. Netrakom P (1999) Structural and functional neuroimaging findings in substance-related disorders. Psychiatr Clin North Am 22:313-329.
13. Ng B (2002) Mania associated with mirtazapine augmentation of fluoxetine. Depress Anxiety 15:46-47.
14. Physicians' desk reference, 56th edn (2002). Remeron (Mirtazapine) Monograph. Montvale, NJ: Medical Economics Company.
15. Radomski JW, Dursun SM, Reveley MA, Kutcher SP (2000) An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 55:218-224.
16. Soutullo CA, McElroy SL, Keck PE (1998:) Hypomania associated with mirtazapine augmentation of sertraline. J Clin Psychiatry 59:320.
17. Stahl SM (2000) Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd Edn. New York: Cambridge University Press.